SCHEMBL21167464

SCHEMBL21167464

COCCOc1ccnc(Nc2ccc(N)c(NCc3ccc4ncccc4c3)n2)c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.36
AURKA O14965 1/20 0.35
RPS6KB1 P23443 1/20 0.35
KDR P35968 6/20 0.35
SYK P43405 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC3 O15379 1/20 0.35
MAPT P10636 1/20 0.34
PDPK1 O15530 1/20 0.34
KLKB1 P03952 2/20 0.34
KLK1 P06870 2/20 0.34
BACE1 P56817 1/20 0.33
HSPA5 P11021 1/20 0.33
HSPA8 P11142 1/20 0.33
CLK1 P49759 1/20 0.33
CLK2 P49760 1/20 0.33
DYRK1A Q13627 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
DYRK1B Q9Y463 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21167623 0.91 KDR (0.42) NPC1KDRSYKHDAC3MAPT
SCHEMBL21167727 0.89 ROCK1 (0.42) NPC1AURKARPS6KB1KDRSYK
SCHEMBL21167721 0.89 KLKB1 (0.37) NPC1AURKARPS6KB1KDRHDAC6
SCHEMBL24591002 0.86 NPC1 (0.35) NPC1AURKARPS6KB1KDRHDAC6
SCHEMBL21167596 0.84 MAPT (0.43) NPC1KDRSYKHDAC6HDAC3
SCHEMBL21167711 0.81 KDR (0.42) NPC1KDRSYKHDAC3MAPT
SCHEMBL22475846 0.81 SYK (0.44) AURKARPS6KB1KDRSYKPDPK1
SCHEMBL22475845 0.81 SYK (0.46) NPC1KDRSYKMAPTPDPK1
SCHEMBL22475963 0.80 KDR (0.43) NPC1KDRSYKMAPTCLK1
SCHEMBL21167713 0.79 GRM5 (0.43) NPC1KDRSYKHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-B1 CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LTD (CN) 2022-07-06 EP disclosed
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed